Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
clinical trials
life sciences
national blog main
boston
boston top stories
fda
san francisco blog main
deals
dyne therapeutics
investing
myotonic dystrophy type 1
rare disease drugs
san diego blog main
480 biomedical
akouos
arsenal medical
astellas pharma
astellas pharmaceuticals
atlas venture
audentes therapeutics
avidity biosciences
biotech ipos
black diamond therapeutics
bladder cancer
bluebird bio
blueprint medicines
bob langer
california institute for biomedical research
cancer
cancer drugs
chronic rhinosinusitis
covid-19
decibel therapeutics
deciphera pharmaceuticals
drug delivery
duchenne muscular dystrophy
eli lilly
endometral cancer
What
ipo
6
×
therapeutics
6
×
developing
drug
medicines
company
million
raised
biotech
dyne
genetic
muscle
new
public
rare
treat
according
affects
ago
americans
approved
based
biotechs
black
brings
cancer
clinic
clinical
companies
considering
data
date
deb
debut
debuted
diamond
diseases
disorders
dyne’s
early
Language
unset
6
×
Current search:
therapeutics
×
ipo
×
unset
×
@techcrunch.com
2 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds